Literature DB >> 16215538

Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma.

I S Yalvac1, U Eksioglu, B Satana, S Duman.   

Abstract

AIMS: To evaluate the surgical success results of Ahmed glaucoma valve (AGV) and Molteno single-plate implant (MSPI) in cases of neovascular glaucoma (NVG).
METHODS: Between May 1997 and May 2002, 38 of 38 NVG patients that underwent implantation of AGV and 27 eyes of 27 NVG patients that underwent MSPI (a total 65 eyes of 65 patients) included to the study.
RESULTS: The cumulative probabilities of success were 63.2% at 1 year, 56.2% at 2 years, 43.2% at 3 years, 37.8% at 4 years, and 25.2% at 5 years in AGV group whereas the cumulative probabilities of success were 37.0% at 1 year, 29.6% at 2 years, 29.6% at 3 years, 29.6% at 4 years, and 29.6% at 5 years in MSPI group (P=0.141). Preoperative visual acuity <2/200 (P=0.003), diagnosis of diabetes mellitius (P=0.050), and preoperative IOP>or=35 mmHg (P=0.038) were found to be poor prognostic factors for surgical success.
CONCLUSIONS: Both AGV and single plate MSPI were successful for early and intermediate-term of IOP control but in long term both implants were failed to achieve control of IOP in patients with NVG.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16215538     DOI: 10.1038/sj.eye.6702125

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  33 in total

Review 1.  Neovascular glaucoma.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2007-08-08       Impact factor: 21.198

Review 2.  Anti-vascular endothelial growth factor for neovascular glaucoma.

Authors:  Arathi Simha; Andrew Braganza; Lekha Abraham; Prasanna Samuel; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2013-10-02

3.  Intravitreal bevacizumab and Ahmed glaucoma valve implantation in patients with neovascular glaucoma.

Authors:  Hai-Tao Zhang; Yu-Xin Yang; Ying-Ying Xu; Rui-Min Yang; Bao-Jun Wang; Jun-Xi Hu
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

4.  [Neovascular glaucoma: aetiology, pathogenesis and treatment].

Authors:  K U Löffler
Journal:  Ophthalmologe       Date:  2006-12       Impact factor: 1.059

5.  Ahmed valve implantation for neovascular glaucoma after 23-gauge vitrectomy in eyes with proliferative diabetic retinopathy.

Authors:  Yu Cheng; Xiao-Hong Liu; Xi Shen; Yi-Sheng Zhong
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

6.  Surgical treatment of neovascular glaucoma: a systematic review and meta-analysis.

Authors:  Zakhar Shchomak; David Cordeiro Sousa; Inês Leal; Luís Abegão Pinto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-02-06       Impact factor: 3.117

7.  The Ahmed glaucoma valve in neovascular glaucoma (An AOS Thesis).

Authors:  Peter A Netland
Journal:  Trans Am Ophthalmol Soc       Date:  2009-12

8.  Graft-free Ahmed tube insertion: a modified method at 5 mm from limbus.

Authors:  Juan Carlos Mesa-Gutiérrez; Juan Lillo-Sopena; Anna Monés-Llivina; Silvia Sanz-Moreno; Jorge Arruga-Ginebreda
Journal:  Clin Ophthalmol       Date:  2010-04-26

9.  A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.

Authors:  Joseph F Panarelli; Michael R Banitt; Steven J Gedde; Wei Shi; Joyce C Schiffman; William J Feuer
Journal:  Ophthalmology       Date:  2015-12-30       Impact factor: 12.079

10.  Intracameral bevacizumab and mitomycin C Trabeculectomy for eyes with neovascular glaucoma: a case series.

Authors:  Carlos Gustavo Vasconcelos de Moraes; Antonio Carlos Facio; José Humberto Costa; Roberto Freire Santiago Malta
Journal:  J Ocul Biol Dis Infor       Date:  2009-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.